SAINT PETERSBURG, FLORIDA (PRWEB) JANUARY 19, 2016
VGI Medical, LLC, a privately held medical device company offering innovative spinal implants, announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the VerteLP Lateral Lumber Cage System. VerteLP represents the latest of lateral lumbar fusion, featuring enhanced bi-cortical plating technology to facilitate simplified cage insertion, and integrated fixation all through a direct, minimally invasive approach. Tov Vestgaarden, Ph.D., President and CEO of VGI Medical, comments, “We are thrilled to strengthen our portfolio of innovative products by introducing the first lateral lumbar cage with integrated in-line plating that achieves bi-cortical fixation. The state-of-the-art VerteLP lateral cage represents the latest in spinal fixation technology and advances the technology to the next level.”
A surgeon panel led by Dr. David Greenwald, M.D., F.A.C.S. in St. Augustine, Florida, was instrumental in consulting with the design and surgical procedure, and shares the company’s enthusiasm about the product. The VerteLP cage and integrated plating are delivered in the plane of the disc through a minimally invasive direct lateral approach, so that the implantation may be achieved with less exposure than may be required of other lateral systems with integrated screws that must be inserted at divergent angles, or integrated lateral plates. The system features thoughtfully designed instrumentation including an inserter that delivers the implant and deploys the plating with simple maneuvers.
VerteLP is compatible with the direct lateral trans-psoatic approach common in the United States. VGI Medical, LLC was founded in 2007 by Tov Vestgaarden, Ph.D in St. Petersburg, FL. VGI Medical, LLC has experienced rapid growth through portfolio expansion in innovative markets. VGI Medical develops unique spine devices and instrumentation designed to support good clinical outcomes while making procedures easier to perform.”